Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
301.50    -0.50 (-0.17%)
Bid:
302.00
Ask:
302.50
Spread: 0.50 (0.166%)
Market Cap: £177.99m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Share Buyback Programme

10 Apr 2025 07:01

RNS Number : 4134E
Treatt PLC
10 April 2025
 

10 April 2025

Treatt PLC

("Treatt" or the "Company")

Share Buyback Programme

Launch of Share Buyback Programme

Treatt PLC, the manufacturer and supplier of natural ingredients for the beverage, flavour and fragrance industries, is pleased to announce it will commence a share buyback programme (the "Share Buyback Programme"), as referenced in the Company's trading update released today.

Treatt has a strong balance sheet and the Board has considered the Share Buyback Programme as part of the Company's capital allocation framework, whilst also reflecting Treatt's strong cash performance together with the Board's confidence in Treatt's strategy and medium term outlook.

Details of the Share Buyback Programme

The Company has appointed its corporate brokers, Investec Bank plc ("Investec") and Peel Hunt LLP ("Peel Hunt") (together, the "Brokers"), to manage the share buyback programme to repurchase ordinary shares of 2 pence each in the capital of the Company (the "Ordinary Shares") on the Company's behalf from 10 April 2025, for a maximum aggregate consideration of £5 million (the "Buyback Amount"). The Share Buyback Programme will run until the earlier of the Buyback Amount being utilised in the repurchase of Ordinary Shares or the expiry of the 2025 Authority (defined below). Shares repurchased will be held in treasury at the Company's discretion for later reissue or cancellation.

Treatt has given irrevocable and non-discretionary instruction to Investec and Peel Hunt to conduct the Share Buyback Programme on its behalf. The Brokers will act as "riskless" or "matched" principals for the purposes of the Share Buyback Programme, within certain parameters, and will make trading decisions concerning the purchases of Ordinary Shares independently of the Company.

Shares purchased under the Share Buyback Programme will take place in open market transactions and in accordance with the general authority to purchase Ordinary Shares granted to the directors of the Company by its shareholders at the Company's annual general meeting in 2025 (the "2025 Authority"). The maximum number of Ordinary Shares which the Company is authorised to purchase under the 2025 Authority is 6,120,976. In accordance with the 2025 Authority, the maximum price (exclusive of expenses) which may be paid for an Ordinary Share is an amount equal to the higher of (i) 5% above the average of the middle market quotations for an Ordinary Share as derived from the London Stock Exchange Daily Official List on the five business days immediately preceding any Ordinary Shares being purchased and (ii) the higher of the price of the last independent trade and the highest current independent bid for Ordinary Shares on the trading venue where the purchase is carried out. Furthermore, in accordance with the 2025 Authority, the minimum price which may be paid for each Ordinary Share is 2 pence, being the nominal value of an Ordinary Share. The Share Buyback Programme will be conducted in accordance with Article 5(1) of Regulation (EU) 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended) ("UK MAR") and the provisions of Commission Delegated Regulation (EU) 2016/1052, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended), which deal with buyback programmes. The Share Buyback Programme will also be conducted in accordance with Chapter 9 of the Financial Conduct Authority's UK Listing Rules.

Treatt will make further regulatory announcements in respect of repurchases of Ordinary Shares as required.

 

For further information, please contact:

 

Treatt PLC

David Shannon, Chief Executive Officer

Ryan Govender, Chief Financial Officer

 

+44 (0) 1284 702500

Investec Bank Plc - Joint Corporate Broker

+44 (0) 20 7597 5970

Patrick Robb

David Anderson

Shalin Bhamra

 

Peel Hunt LLP - Joint Corporate Broker

+44 (0) 20 7418 8900

George Sellar

Andrew Clark

Finn Nugent

 

MHP - Financial PR

+44 (0) 20 3128 8100

Tim Rowntree

Eleni Menikou

Veronica Farah

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSSEFUEISEIL
Date   Source Headline
28th Oct 20143:00 pmRNSVoting Rights and Capital
23rd Oct 20142:38 pmRNSDirector/PDMR Shareholding
7th Oct 20144:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20141:50 pmRNSDirector/PDMR Shareholding
1st Oct 20147:00 amRNSTrading Statement
30th Sep 20144:02 pmRNSTotal Voting Rights
29th Sep 20144:25 pmRNSDirector/PDMR Shareholding
1st Sep 20149:22 amRNSDirector/PDMR Shareholding
29th Aug 20147:00 amRNSTotal Voting Rights
1st Aug 20142:25 pmRNSDirector/PDMR Shareholding
29th Jul 201410:03 amRNSDirector/PDMR Shareholding
29th Jul 20147:00 amRNSInterim Management Statement
1st Jul 20143:44 pmRNSDirector/PDMR Shareholding
1st Jul 20148:32 amRNSDirector/PDMR Shareholding
30th Jun 20143:17 pmRNSHolding(s) in Company
23rd May 20144:39 pmRNSHolding(s) in Company
20th May 20147:00 amRNSHalf Year Results
19th May 20149:47 amRNSVoting Rights and Capital
16th May 201412:07 pmRNSResult of EGM
16th Apr 20141:41 pmRNSNotice of EGM
9th Apr 20142:34 pmRNSDirector/PDMR Shareholding
7th Apr 201410:56 amRNSNotice of EGM
24th Feb 20145:12 pmRNSResult of AGM
10th Feb 20147:00 amRNSInterim Management Statement
31st Dec 20137:00 amRNSAnnual Information Update
23rd Dec 20134:35 pmRNSDirector/PDMR Shareholding
19th Dec 201310:32 amRNSAnnual Financial Report
13th Dec 20139:48 amRNSDirector/PDMR Shareholding
9th Dec 20137:00 amRNSFinal Results
22nd Oct 20134:22 pmRNSDirector/PDMR Shareholding
17th Oct 20132:53 pmRNSDirector/PDMR Shareholding
30th Sep 201312:54 pmRNSVoting Rights and Capital
30th Sep 20137:00 amRNSTrading Statement
26th Sep 20133:17 pmRNSDirector/PDMR Shareholding
13th Sep 201310:54 amRNSHolding(s) in Company
3rd Sep 20139:23 amRNSDirector/PDMR Shareholding
1st Aug 20137:00 amRNSInterim Management Statement
31st Jul 20132:14 pmRNSVoting Rights and Capital
29th Jul 201310:48 amRNSDirector/PDMR Shareholding
23rd Jul 20135:01 pmRNSHolding(s) in Company
15th Jul 20133:37 pmRNSDirector/PDMR Shareholding
15th Jul 201310:49 amRNSHolding(s) in Company
12th Jul 201312:50 pmRNSDirector/PDMR Shareholding
10th Jul 20134:31 pmRNSSale of Interest in Treatt plc
10th Jul 20134:28 pmRNSBovill Family Concert Party Placing
31st May 201310:17 amRNSDirector/PDMR Shareholding
28th May 20137:00 amRNSTrading Statement
24th May 201310:54 amRNSDirectorate Change
14th May 201310:56 amRNSDirector/PDMR Shareholding
13th May 20137:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.